Fig. 1.
Fig. 1. Fibrinogen inhibits ADP-evoked elevations in [Ca++]i. / (A) Fura-2–loaded human platelets suspended in an HBS containing 1 mM Ca++ were stimulated with ADP (5 μM) in the absence (Control) or presence of various concentrations of fibrinogen (FG; 0.1-1 mg/mL). [Ca++]i was monitored as described in “Materials and methods.” (B, C) Human platelets were stimulated with ADP (5 μM) in the absence (Control) or presence of either fibrinogen alone (FG; 1 mg/mL) or fibrinogen (1 mg/mL) in combination with RGDS (100 μM) (FG + RGDS; B) or abciximab (5 μg/mL) (ReoPro; FG + Ab; C). Traces shown are representative of 5 independent experiments.

Fibrinogen inhibits ADP-evoked elevations in [Ca++]i.

(A) Fura-2–loaded human platelets suspended in an HBS containing 1 mM Ca++ were stimulated with ADP (5 μM) in the absence (Control) or presence of various concentrations of fibrinogen (FG; 0.1-1 mg/mL). [Ca++]i was monitored as described in “Materials and methods.” (B, C) Human platelets were stimulated with ADP (5 μM) in the absence (Control) or presence of either fibrinogen alone (FG; 1 mg/mL) or fibrinogen (1 mg/mL) in combination with RGDS (100 μM) (FG + RGDS; B) or abciximab (5 μg/mL) (ReoPro; FG + Ab; C). Traces shown are representative of 5 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal